Type 2 Diabetes Therapeutics | Brighthaven Ventures, LLC

Product description

Lead development program for a novel therapeutic targeting Type 2 Diabetes, currently in Phase 2 clinical trials.

B
Brighthaven Ventures, LLC
Research Triangle Park, United States (US)

Price: N/A